These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 10648389)

  • 21. Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study.
    Oh SY; Kim WS; Kim JS; Kim SJ; Lee S; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Kang HJ; Choi CW; Park J; Kim HJ; Kwon JH; Lee HS; Lee GW; Eom HS; Kwak JY; Lee WS; Suh C; Kim HJ
    Int J Hematol; 2010 Oct; 92(3):510-7. PubMed ID: 20838958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type.
    Raderer M; Traub T; Formanek M; Virgolini I; Osterreicher C; Fiebiger W; Penz M; Jäger U; Pont J; Chott A; Kurtaran A
    Br J Cancer; 2001 Nov; 85(10):1462-6. PubMed ID: 11720429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination.
    Arcaini L; Burcheri S; Rossi A; Passamonti F; Paulli M; Boveri E; Brusamolino E; Orlandi E; Molteni A; Pulsoni A; Cox MC; Orsucci L; Fabbri A; Frezzato M; Voso MT; Zaja F; Montanari F; Pascutto C; Morra E; Cortelazzo S; Lazzarino M
    Oncologist; 2006 Mar; 11(3):285-91. PubMed ID: 16549813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged follow-up on lenalidomide-based treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma)-Real-world data from the Medical University of Vienna.
    Kiesewetter B; Lamm W; Neuper O; Mayerhoefer ME; Simonitsch-Klupp I; Raderer M
    Hematol Oncol; 2019 Oct; 37(4):345-351. PubMed ID: 31283840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa.
    Lee JL; Kim MK; Lee KH; Hyun MS; Chung HS; Kim DS; Shin SO; Cho HS; Bae SH; Ryoo HM
    Ann Hematol; 2005 Jan; 84(1):13-8. PubMed ID: 15309523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
    Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
    J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the clinical characteristics and prognostic factors of gastrointestinal mucosa-associated lymphoid tissue (MALT) lymphoma.
    Xu X; Wang Z; Yu Y; Wang Y; Zhang L; Sun B; Da W; Zhang Y
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1678-84. PubMed ID: 24730769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience.
    Raderer M; Wöhrer S; Streubel B; Troch M; Turetschek K; Jäger U; Skrabs C; Gaiger A; Drach J; Puespoek A; Formanek M; Hoffmann M; Hauff W; Chott A
    J Clin Oncol; 2006 Jul; 24(19):3136-41. PubMed ID: 16769982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases.
    Jaso J; Chen L; Li S; Lin P; Chen W; Miranda RN; Konoplev S; Medeiros LJ; Yin CC
    Hum Pathol; 2012 Sep; 43(9):1436-43. PubMed ID: 22406370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical characteristics and diagnosis of pulmonary mucosa-associated lymphoid tissue-derived (MALT) lymphoma: a retrospective analysis of 29 cases].
    Li AW; Xu JF; Zhou CC; Wu CY; Wang YL
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):390-3. PubMed ID: 22883464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study.
    Oh SY; Kim WS; Kim JS; Kim SJ; Lee S; Lee DH; Kang HJ; Song MK; Kim HJ; Kwon JH; Kwak JY; Park BB; Do YR; Jeong SH; Suh C
    Acta Haematol; 2012; 127(2):100-4. PubMed ID: 22178776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands: a multicenter Rare Cancer Network study.
    Anacak Y; Miller RC; Constantinou N; Mamusa AM; Epelbaum R; Li Y; Calduch AL; Kowalczyk A; Weber DC; Kadish SP; Bese N; Poortmans P; Kamer S; Ozsahin M
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):315-20. PubMed ID: 21075560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysis.
    Wöhrer S; Kiesewetter B; Fischbach J; Müllauer L; Troch M; Lukas J; Mayerhoefer ME; Raderer M
    Ann Hematol; 2014 Aug; 93(8):1287-95. PubMed ID: 24633660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relapsed or refractory nongastric marginal zone B-cell lymphoma: multicenter retrospective analysis of 92 cases.
    Oh SY; Kim WS; Kim SJ; Kim JS; Kim SH; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Kim JG; Yang DH; Kang HJ; Choi CW; Park J; Choi YJ; Kim HJ; Kwon JH; Suh C; Kim HJ
    Am J Hematol; 2009 Dec; 84(12):826-9. PubMed ID: 19890833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term Clinical Outcomes of Optimizing Combination Therapy for Primary Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma: A Retrospective Study.
    Min GJ; Rhee CK; Kim TY; Jeon YW; O JH; Choi BO; Park G; Cho SG
    Acta Haematol; 2024; 147(4):413-426. PubMed ID: 38008071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subtle CD20 positivity in the bone marrow of a patient who has a mucosa-associated lymphoid tissue lymphoma should not be regarded as evidence of involvement in the bone marrow.
    Won D; Park CJ; Shim H; Jang S; Chi HS; Huh J; Yoon DH; Suh C
    Histopathology; 2013 Feb; 62(3):397-405. PubMed ID: 23163529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation: natural history and patterns of disease progression.
    Liao Z; Ha CS; McLaughlin P; Manning JT; Hess M; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):399-403. PubMed ID: 10974453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-MALT marginal zone lymphomas.
    Thieblemont C
    Ann Oncol; 2008 Jun; 19 Suppl 4():iv70-3. PubMed ID: 18519410
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical and pathologic characterization of mucosa-associated lymphoid tissue lymphoma of the head and neck.
    Bhattacharyya N; Frankenthaler RA; Gomolin HI; Kadin ME; Lauretano AM
    Ann Otol Rhinol Laryngol; 1998 Sep; 107(9 Pt 1):801-6. PubMed ID: 9749552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological aspects of mucosa-associated lymphoid tissue (MALT) lymphoma of the parotid gland: a retrospective single-center analysis of 28 cases.
    Troch M; Formanek M; Streubel B; Müllauer L; Chott A; Raderer M
    Head Neck; 2011 Jun; 33(6):763-7. PubMed ID: 20737498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.